The Potential Benefits of Low Dose Naltrexone LDN for Autoimmune, Pain & Inflammatory Conditions in California

ScriptWorks Pharmacy, located in Walnut Creek, California, provides patients and healthcare providers with access to compounded medications, including low-dose naltrexone (LDN). As interest grows in alternatives that may support the body’s response to inflammation and immune dysregulation, so does consideration of the potential benefits of naltrexone in various clinical contexts.
Why CA Docs Prescribe Low Dose Naltrexone (LDN) for Fibromyalgia, Multiple Sclerosis, Crohn’s Disease, and Chronic Pain?

Compounded at significantly lower doses (typically 0.5 mg to 4.5 mg) than standard naltrexone used for opioid addiction, potential LDN benefits may include addressing conditions involving inflammation, immune dysfunction, and chronic pain.
California Thyroid Disease Pharmacy: Autoimmune Conditions, Hashimoto’s Thyroiditis (HT), Graves’ Disease (GD), & More

When dysfunctional thyroid performance occurs, the impact can be devastating. Many patients on thyroid replacement therapy (TRT) are still not happy with how they feel.
Low Dose Naltrexone (LDN): Frequently Asked Questions (FAQs)

At ScriptWorks Pharmacy, we get tons of questions about Low Dose Naltrexone (LDN) every day.
Topical Pain Medication: Compounding Personalized Pain Management Options

Topical pain medications are applied externally and are absorbed through the skin. Optimal viscosity, compatibility with the active ingredient, and skin compatibility should be considered.
A Deeper Look into Low Dose Naltrexone (LDN): Research & Insights

Naltrexone is an opiate receptor antagonist. The 50-mg dose of Naltrexone was approved by the FDA for opioid and alcohol addiction in 1984. At much lower doses (0.5–9 mg per day), it may provide relief to patients suffering from autoimmune diseases, chronic pain, mental health diseases, and inflammation.
Low Dose Naltrexone: A Medical Game Changer

ScriptWorks has spent hours and hours researching and collaborating with healthcare professionals on Low Dose Naltrexone since 2014. Doctors and pharmacists around the world continue to study this fascinating therapy.